Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |